KIM
BSX icon

Kane Investment Management’s Boston Scientific BSX Stock Holding History

Kane Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,585
Closed -$628K – 101
2025
Q4 		$628K Sell
6,585
-1,580
-19% -$155K 0.3% 62
2025
Q3 		$797K Sell
8,165
-1,402
-15% -$145K 0.39% 52
2025
Q2 		$1.03M Sell
9,567
-1,047
-10% -$106K 0.54% 46
2025
Q1 		$1.07M Buy
10,614
+2,560
+32% +$258K 0.52% 41
2024
Q4 		$719K Buy
+8,054
New +$709K 0.4% 60

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kane Investment Management's BSX Position: Q1 2026 in Review

Kane Investment Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,585 shares — an estimated $628K sold.

Kane Investment Management first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $1.07M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Kane Investment Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Kane Investment Management sold 6,585 Boston Scientific shares in Q1 2026, an estimated $628K.
  • Kane Investment Management first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • Kane Investment Management's Boston Scientific position peaked at $1.07M in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Kane Investment Management's 13F filing for Q1 2026, filed 14 May 2026.